LumaCyte
Renee A. Hart has a diverse work experience spanning multiple industries. Renee A.'smost recent role was as the President & Chief Business Officer at LumaCyte, a company specializing in label-free single cell analysis and sorting instrumentation. Prior to that, they were a Managing Member of the Board of Directors at LumaCyte. Before joining LumaCyte, they worked at Medidata Solutions as the Senior Vice President of Global Partners Business. Renee A. also served as the Vice President of Strategic Accounts at Clinipace Worldwide and as an Executive Director of Global Strategic Accounts at inVentiv Health. Renee A. Hart started their career as a Senior Biopharmaceutical Specialist at Amgen and then moved on to Purdue Pharma where they held the position of Medical Marketing Representative/District Manager. Renee A. began their career in pharmaceuticals as a Senior Pharmaceutical Representative at Novartis. Additionally, they had experience in sales and provider development as the Director of Sales and Provider Development at Privia Health. Overall, Renee A. Hart has a wide range of experience in business development, strategic accounts management, and pharmaceutical sales and marketing.
Renee A. Hart attended Marshall University from 1991 to 1996, where they obtained a Bachelor of Science degree in Biology/Chemistry.
LumaCyte
LumaCyte provides researchers with a diagnostic tool that accelerates medical discoveries through a novel approach to cell analysis and sorting. Its patented technology empowers researchers to ask questions and seek answers without the bias of antibody-based diagnostics. Its technology is intended to significantly broaden the horizons of medicalresearch and shorten the time to powerful medical breakthroughs.